Clostridium News and Research

RSS

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

14 Feb 2021

Researchers develop new weapon to fight against resistant bacteria

Every day, people die from simple infections even though they have been treated with antibiotics. This is because more and more bacteria have become resistant to the types of antibiotics that doctors can prescribe.

10 Feb 2021

Study: Vast majority of U.S. infants may be suffering from gut microbiome deficiency

A new peer-reviewed study reveals that the vast majority of U.S. infants may be suffering from a substantial deficiency in an important bacterium key to breast milk utilization and immune system development, as well as protection against gut pathogens linked to common newborn conditions such as colic and diaper rash.

21 Jan 2021

COVID-19 has transformed the world of vaccines

Researchers at GlaxoSmithKline (GSK) in Italy and Belgium say the coronavirus disease 2019 (COVID-19) pandemic is transforming the world of vaccinology by accelerating vaccine development and the availability of powerful technologies.

20 Jan 2021

New approach to tame botulinum toxin for drug delivery

While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum -- the most potent toxins known.

8 Jan 2021

Gut and oral microbiomes predict COVID-19 severity

One question that continues to remain unanswered during the ongoing coronavirus disease 2019 (COVID-19) pandemic has been why is there a distinctive hit-and-miss pattern when it comes to severe disease? An interesting new study that appears on the medRxiv* preprint server pinpoints one highly relevant risk factor: the state of the oral and gut microbiomes.

7 Jan 2021

Children’s hospitals are partly to blame as superbugs increasingly attack kids

A memory haunts Christina Fuhrman: the image of her toddler Pearl lying pale and listless in a hospital bed, tethered to an IV to keep her hydrated as she struggled against a superbug infection.

4 Jan 2021

New, rapid antibody test gives detailed information on how the immune system reacts to Covid-19

A new type of antibody test is being developed by researchers at Linnaeus University and the bioanalysis company Attana. Compared to the binary antibody tests used today, this rapid test can give more detailed information on how our immune systems react to Covid-19 and other types of viruses and bacteria.

29 Dec 2020

Study assesses link between secondary bloodstream infection and severe COVID-19

People with severe COVID-19 and a secondary blood infection were significantly sicker upon hospital admission, had longer hospital stays and poorer outcomes, according to a Rutgers study.

23 Dec 2020

Researchers pinpoint key factors to ensure successful fecal microbiota transplants

Could number two be number one when it comes to combating recurrent Clostridium difficile (CDI) infections?Using genetic material analysis and machine learning, UBC researchers have pinpointed several key factors to ensure successful fecal microbiota transplants (FMT), which have proven successful in treating bacterial infections in the gut including illnesses like C. difficile, Crohn's Disease, Colitis and even obesity, explains lead author Negin Kazemian.

10 Dec 2020

Study examines effect of low-dose vancomycin to treat clostridium difficile infection

Clostridium difficile infection (CDI) is inflammation of the colon caused by a bacteria called clostridium difficile and is the most common cause of infectious diarrhea in hospitalized patients.

8 Dec 2020

Clonal hematopoiesis linked to severe COVID-19

Now, an international team of researchers from the USA, South Korea and Canada has found that clonal hematopoiesis is tied to the risk of severe COVID-19.

30 Nov 2020

Researchers use genomic tools and supercomputers to study the infant gut microbiome

Since 2017, University of Alabama at Birmingham researchers Casey Morrow, Ph.D., and Hyunmin Koo, Ph.D., have used powerful genomic tools and supercomputers that analyze massive amounts of genetic data to identify individual strains within single species of the gut microbiome.

29 Oct 2020

Fecal microbiota transplantation restores gut microbial development in cesarean-born infants

The human gut contains a diverse ecosystem of microbes: mainly bacteria, as well as viruses and fungi, termed the gut microbiota. Recent years have shown that the gut microbiota have widespread effects on the overall functioning of the host's body.

1 Oct 2020

New AGA report details effectiveness and safety of fecal microbiota transplantation

Today, the American Gastroenterological Association released the first results from the NIH-funded AGA Fecal Microbiota Transplantation National Registry, the largest real-world study on the safety and effectiveness of FMT.

1 Oct 2020

Researchers identify pathogen responsible for creeping migration of fat in Crohn's patients

In many patients with Crohn's disease, abdominal fat migrates to the wall of the inflamed small intestines. What prompts the fat tissue to "creep" through the abdomen and wrap around the intestines of many patients with this inflammatory bowel disease (IBD) has been an enduring mystery.

1 Oct 2020

Clostridium News and Research

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Researchers develop new weapon to fight against resistant bacteria

Study: Vast majority of U.S. infants may be suffering from gut microbiome deficiency

COVID-19 has transformed the world of vaccines

New approach to tame botulinum toxin for drug delivery

Gut and oral microbiomes predict COVID-19 severity

Children’s hospitals are partly to blame as superbugs increasingly attack kids

New, rapid antibody test gives detailed information on how the immune system reacts to Covid-19

Study assesses link between secondary bloodstream infection and severe COVID-19

Researchers pinpoint key factors to ensure successful fecal microbiota transplants

Study examines effect of low-dose vancomycin to treat clostridium difficile infection

Clonal hematopoiesis linked to severe COVID-19

Researchers use genomic tools and supercomputers to study the infant gut microbiome

Fecal microbiota transplantation restores gut microbial development in cesarean-born infants

New AGA report details effectiveness and safety of fecal microbiota transplantation

Researchers identify pathogen responsible for creeping migration of fat in Crohn's patients

Gut microbiome may play a part in severe COVID-19

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Easy-to-use software developed to identify drug-resistant genes in bacteria

Fecal microbial transplantation more effective, cost-efficient treatment than antibiotics

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News